Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Healthcare Triangle (HCTI) EBITDA Margin (2020 - 2025)

Historic EBITDA Margin for Healthcare Triangle (HCTI) over the last 6 years, with Q3 2025 value amounting to 54.46%.

  • Healthcare Triangle's EBITDA Margin fell 27000.0% to 54.46% in Q3 2025 from the same period last year, while for Sep 2025 it was 42.63%, marking a year-over-year decrease of 85100.0%. This contributed to the annual value of 40.35% for FY2024, which is 173200.0% down from last year.
  • As of Q3 2025, Healthcare Triangle's EBITDA Margin stood at 54.46%, which was down 27000.0% from 38.19% recorded in Q2 2025.
  • In the past 5 years, Healthcare Triangle's EBITDA Margin ranged from a high of 4.68% in Q2 2021 and a low of 94.25% during Q4 2022
  • Its 5-year average for EBITDA Margin is 31.8%, with a median of 32.45% in 2023.
  • Its EBITDA Margin has fluctuated over the past 5 years, first tumbled by -580700bps in 2022, then soared by 753900bps in 2023.
  • Quarter analysis of 5 years shows Healthcare Triangle's EBITDA Margin stood at 36.18% in 2021, then tumbled by -160bps to 94.25% in 2022, then surged by 80bps to 18.87% in 2023, then tumbled by -111bps to 39.82% in 2024, then plummeted by -37bps to 54.46% in 2025.
  • Its EBITDA Margin stands at 54.46% for Q3 2025, versus 38.19% for Q2 2025 and 37.42% for Q1 2025.